A detailed history of Mercer Global Advisors Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Mercer Global Advisors Inc holds 221,029 shares of NVO stock, worth $18.7 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
221,029
Previous 204,581 8.04%
Holding current value
$18.7 Million
Previous $29.2 Million 9.88%
% of portfolio
0.06%
Previous 0.07%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$119.07 - $145.42 $1.96 Million - $2.39 Million
16,448 Added 8.04%
221,029 $26.3 Million
Q2 2024

Aug 12, 2024

BUY
$122.71 - $146.91 $985,361 - $1.18 Million
8,030 Added 4.09%
204,581 $29.2 Million
Q1 2024

May 15, 2024

SELL
$102.11 - $135.92 $638,698 - $850,179
-6,255 Reduced 3.08%
196,551 $25.5 Million
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $1.09 Million - $1.31 Million
12,430 Added 6.53%
202,806 $21 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $8.75 Million - $19.2 Million
96,214 Added 102.18%
190,376 $17.3 Million
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $1.48 Million - $1.64 Million
9,507 Added 11.23%
94,162 $15.2 Million
Q1 2023

May 15, 2023

SELL
$132.34 - $159.14 $288,236 - $346,606
-2,178 Reduced 2.51%
84,655 $13.5 Million
Q4 2022

Feb 08, 2023

SELL
$102.55 - $135.33 $1.07 Million - $1.42 Million
-10,477 Reduced 10.77%
86,833 $11.8 Million
Q3 2022

Nov 15, 2022

SELL
$95.28 - $116.93 $182,461 - $223,920
-1,915 Reduced 1.93%
97,310 $9.7 Million
Q2 2022

Aug 10, 2022

BUY
$103.24 - $121.81 $978,715 - $1.15 Million
9,480 Added 10.56%
99,225 $11.1 Million
Q1 2022

May 10, 2022

SELL
$93.1 - $112.54 $1.07 Million - $1.29 Million
-11,463 Reduced 11.33%
89,745 $9.97 Million
Q4 2021

Feb 04, 2022

BUY
$95.88 - $117.08 $224,071 - $273,615
2,337 Added 2.36%
101,208 $11.3 Million
Q3 2021

Nov 10, 2021

BUY
$84.42 - $106.62 $841,160 - $1.06 Million
9,964 Added 11.21%
98,871 $9.49 Million
Q2 2021

Aug 10, 2021

BUY
$67.66 - $84.76 $252,371 - $316,154
3,730 Added 4.38%
88,907 $7.45 Million
Q1 2021

May 11, 2021

BUY
$67.06 - $75.82 $75,911 - $85,828
1,132 Added 1.35%
85,177 $5.74 Million
Q4 2020

Feb 12, 2021

BUY
$63.89 - $73.8 $136,149 - $157,267
2,131 Added 2.6%
84,045 $5.87 Million
Q3 2020

Dec 10, 2020

BUY
$63.69 - $70.22 $1.5 Million - $1.65 Million
23,534 Added 40.31%
81,914 $5.69 Million
Q2 2020

Aug 10, 2020

BUY
$58.54 - $67.94 $902,569 - $1.05 Million
15,418 Added 35.89%
58,380 $3.82 Million
Q1 2020

May 18, 2020

BUY
$49.46 - $64.78 $823,459 - $1.08 Million
16,649 Added 63.27%
42,962 $2.59 Million
Q4 2019

Feb 13, 2020

BUY
$49.86 - $58.26 $21,689 - $25,343
435 Added 1.68%
26,313 $1.52 Million
Q3 2019

Nov 12, 2019

BUY
$47.54 - $53.43 $161,778 - $181,822
3,403 Added 15.14%
25,878 $1.34 Million
Q2 2019

Aug 14, 2019

BUY
$46.79 - $52.47 $56,007 - $62,806
1,197 Added 5.63%
22,475 $1.15 Million
Q1 2019

Apr 23, 2019

SELL
$46.36 - $52.63 $138,477 - $157,205
-2,987 Reduced 12.31%
21,278 $1.11 Million
Q1 2019

Apr 12, 2019

BUY
$46.36 - $52.63 $1.12 Million - $1.28 Million
24,265 New
24,265 $1.12 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $191B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Mercer Global Advisors Inc Portfolio

Follow Mercer Global Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.